Laurie Stelzer - Aug 9, 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
Chief Financial Officer
Signature
/s/ John Moriarty, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Aug 9, 2023
Transactions value $
$824,989
Form type
4
Date filed
8/10/2023, 04:26 PM
Previous filing
Jun 12, 2023
Next filing
Nov 27, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $825K +22.3K +27.87% $37.00 102K Aug 9, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the one year anniversary of the grant date.